Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rappuoli

Showing results (201-210 of 314) with videos related to

Pageof 32
Sort By:
Molecular Microbiology|January 14, 1998
Helicobacter pylori toxin VacA induces vacuole formation by acting in the cell cytosolM de Bernard, B Arico, E Papini, et al.
Infection and Immunity|February 1, 1991
Properties of pertussis toxin mutant PT-9K/129G after formaldehyde treatmentL Nencioni, G Volpini, S Peppoloni, et al.
Infection and Immunity|May 1, 1994
Formaldehyde treatment of proteins can constrain presentation to T cells by limiting antigen processingA di Tommaso, M T de Magistris, M Bugnoli, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 1994
Cellular vacuoles induced by Helicobacter pylori originate from late endosomal compartmentsE Papini, M de Bernard, E Milia, et al.
Infection and Immunity|July 23, 1998
Binding of the Helicobacter pylori vacuolating cytotoxin to target cellsP Massari, R Manetti, D Burroni, et al.
Infection and Immunity|March 1, 1992
Cellular pertussis vaccine containing a Bordetella pertussis strain that produces a nontoxic pertussis toxin moleculeI Marsili, M Pizza, F Giovannoni, et al.
Immunobiology|February 1, 1992
Development and clinical testing of an acellular pertussis vaccine containing genetically detoxified pertussis toxinR Rappuoli, M Pizza, M T De Magistris, et al.
Infection and Immunity|January 1, 1995
Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxinZ Xiang, S Censini, P F Bayeli, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 1995
Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvantsG Douce, C Turcotte, I Cropley, et al.
Vaccine|April 20, 2013
Strategic priorities for respiratory syncytial virus (RSV) vaccine developmentL J Anderson, P R Dormitzer, D J Nokes, et al.
Pageof 32

Showing results (201-210 of 314) with videos related to

Sort By:
Pageof 32
Molecular Microbiology|January 14, 1998
Helicobacter pylori toxin VacA induces vacuole formation by acting in the cell cytosolM de Bernard, B Arico, E Papini, et al.
Infection and Immunity|February 1, 1991
Properties of pertussis toxin mutant PT-9K/129G after formaldehyde treatmentL Nencioni, G Volpini, S Peppoloni, et al.
Infection and Immunity|May 1, 1994
Formaldehyde treatment of proteins can constrain presentation to T cells by limiting antigen processingA di Tommaso, M T de Magistris, M Bugnoli, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 1994
Cellular vacuoles induced by Helicobacter pylori originate from late endosomal compartmentsE Papini, M de Bernard, E Milia, et al.
Infection and Immunity|July 23, 1998
Binding of the Helicobacter pylori vacuolating cytotoxin to target cellsP Massari, R Manetti, D Burroni, et al.
Infection and Immunity|March 1, 1992
Cellular pertussis vaccine containing a Bordetella pertussis strain that produces a nontoxic pertussis toxin moleculeI Marsili, M Pizza, F Giovannoni, et al.
Immunobiology|February 1, 1992
Development and clinical testing of an acellular pertussis vaccine containing genetically detoxified pertussis toxinR Rappuoli, M Pizza, M T De Magistris, et al.
Infection and Immunity|January 1, 1995
Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxinZ Xiang, S Censini, P F Bayeli, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 1995
Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvantsG Douce, C Turcotte, I Cropley, et al.
Vaccine|April 20, 2013
Strategic priorities for respiratory syncytial virus (RSV) vaccine developmentL J Anderson, P R Dormitzer, D J Nokes, et al.
Pageof 32